Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2007-01-08 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LA FERTE-GAUCHER (77320), Seine-et-Marne
SELARL PHARMACIE DU COEUR DE LA BRIE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU COEUR DE LA BRIE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LA FERTE-GAUCHER (77320),
this company of category PME
shows in 2017 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU COEUR DE LA BRIE (SIREN 493803050)
Indicator
2024
2023
2022
2021
2020
2019
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
2 887 219 €
3 026 643 €
Net income
656 166 €
693 321 €
665 206 €
552 734 €
575 291 €
505 214 €
336 802 €
389 757 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
492 545 €
574 912 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
11.7%
12.9%
Revenue and income statement
In 2024, SELARL PHARMACIE DU COEUR DE LA BRIE generates positive net income of 656 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 390 k€ -> 656 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
656 166 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 27%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 73%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
26.678%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
72.897%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU COEUR DE LA BRIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2020
2021
2022
2023
2024
Debt ratio
17.071
6.869
77.129
62.882
53.011
42.889
34.016
26.678
Financial autonomy
75.633
83.984
52.062
56.87
59.121
62.445
68.325
72.897
Repayment capacity
0.853
0.45
None
None
None
None
None
None
Cash flow / Revenue
13.471%
11.785%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
26.682024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good
In 2024, the debt ratio of SELARL PHARMACIE DU COEUR... (26.68) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
72.9%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+8 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DU COEUR... (72.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 354.28. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
354.278
Liquidity indicators evolution SELARL PHARMACIE DU COEUR DE LA BRIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2019
2020
2021
2022
2023
2024
Liquidity ratio
325.086
328.299
246.462
290.582
307.344
297.253
311.475
354.278
Interest coverage
1.472
1.001
None
None
None
None
None
None
Sector positioning
Liquidity ratio
354.282024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of SELARL PHARMACIE DU COEUR... (354.28) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DU COEUR DE LA BRIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2020
2021
2022
2023
2024
Operating WCR
290 558 €
345 340 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
28
33
0
0
0
0
0
0
Customer payment term (days)
14
13
0
0
0
0
0
0
Supplier payment term (days)
35
31
0
0
0
0
0
0
Positioning of SELARL PHARMACIE DU COEUR DE LA BRIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DU COEUR DE LA BRIE is estimated at
9 160 562 €
(range 6 379 270€ - 13 704 725€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
6379k€9160k€13704k€
9 160 562 €Range: 6 379 270€ - 13 704 725€
NAF 5 année 2024
Valuation method used
Net Income Multiple
656 166 €
×
14.0x
=9 160 562 €
Range: 6 379 271€ - 13 704 726€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU COEUR DE LA BRIE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU COEUR DE LA BRIE
What is the revenue of SELARL PHARMACIE DU COEUR DE LA BRIE ?
The revenue of SELARL PHARMACIE DU COEUR DE LA BRIE in 2017 is 2.9 M€.
Is SELARL PHARMACIE DU COEUR DE LA BRIE profitable?
Yes, SELARL PHARMACIE DU COEUR DE LA BRIE generated a net profit of 656 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DU COEUR DE LA BRIE ?
The headquarters of SELARL PHARMACIE DU COEUR DE LA BRIE is located in LA FERTE-GAUCHER (77320), in the department Seine-et-Marne.
Where to find the tax return of SELARL PHARMACIE DU COEUR DE LA BRIE ?
The tax return of SELARL PHARMACIE DU COEUR DE LA BRIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU COEUR DE LA BRIE operate?
SELARL PHARMACIE DU COEUR DE LA BRIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart